Journal of Lipid Research, Vol 29, 1603-1611, Copyright © 1988 by Lipid Research, Inc.

ARTICLES

Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein

T Demant, LA Carlson, L Holmquist, F Karpe, P Nilsson-Ehle, CJ Packard and J Shepherd
University Department of Biochemistry, Royal Infirmary, Glasgow, UK.

Hepatic lipase deficiency produces significant distortion in the plasma lipoprotein profile. Particles with reduced electrophoretic mobility appear in very low density lipoprotein (VLDL). Intermediate density lipoprotein (IDL) increases markedly in the circulation and plasma low density lipoprotein (LDL) levels fall. At the same time there is a mass redistribution within the high density lipoprotein (HDL) spectrum leading to dominance in the less dense HDL2 subfraction. The present study examines apolipoprotein B turnover in a patient with hepatic lipase deficiency. The metabolism of large and small very low density lipoproteins was determined in four control subjects and compared to the pattern seen in the patient. Absence of the enzyme did not affect the rate at which large very low density lipoproteins were converted to smaller particles within this density interval (i.e., of VLDL). However, subsequent transfer of small very low density lipoproteins to intermediate density particles was retarded by 50%, explaining the abnormal accumulation of VLDL in the patient's plasma. Despite this, intermediate density particles accumulated to a level 2.4-times normal because their subsequent conversion to low density lipoprotein has been almost totally inhibited. Consequently, the plasma concentration of low density lipoprotein was only 10% of normal. On the basis of these observations, hepatic lipase appears to be essential for the conversion of small very low density and intermediate density particles to low density lipoproteins. The pathways of direct plasma catabolism of these species were not affected by the enzyme defect. In vitro studies were performed by adding purified hepatic lipase to the patient's plasma.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. L. Karackattu, B. Trigatti, and M. Krieger Hepatic Lipase Deficiency Delays Atherosclerosis, Myocardial Infarction, and Cardiac Dysfunction and Extends Lifespan in SR-BI/Apolipoprotein E Double Knockout Mice Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 548 - 554. [Abstract] [Full Text] [PDF]

				F. Magkos, D. C. Wright, B. W. Patterson, B. S. Mohammed, and B. Mittendorfer Lipid metabolism response to a single, prolonged bout of endurance exercise in healthy young men Am J Physiol Endocrinol Metab, February 1, 2006; 290(2): E355 - E362. [Abstract] [Full Text] [PDF]

				I. L. Ruel, P. Couture, J. S. Cohn, A. Bensadoun, M. Marcil, and B. Lamarche Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism J. Lipid Res., August 1, 2004; 45(8): 1528 - 1537. [Abstract] [Full Text] [PDF]

				M. Verges, A. Bensadoun, J. Herz, J. D. Belcher, and R. J. Havel Endocytosis of Hepatic Lipase and Lipoprotein Lipase into Rat Liver Hepatocytes in Vivo Is Mediated by the Low Density Lipoprotein Receptor-related Protein J. Biol. Chem., March 5, 2004; 279(10): 9030 - 9036. [Abstract] [Full Text] [PDF]

				H. L. Dichek, K. Qian, and N. Agrawal The bridging function of hepatic lipase clears plasma cholesterol in LDL receptor-deficient "apoB-48-only" and "apoB-100-only" mice J. Lipid Res., March 1, 2004; 45(3): 551 - 560. [Abstract] [Full Text] [PDF]

				M. Rizzo, J. M. Taylor, C. M. Barbagallo, K. Berneis, P. J. Blanche, and R. M. Krauss Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 141 - 146. [Abstract] [Full Text] [PDF]

				I. L. Ruel, P. Couture, C. Gagne, Y. Deshaies, J. Simard, R. A. Hegele, and B. Lamarche Characterization of a novel mutation causing hepatic lipase deficiency among French Canadians J. Lipid Res., August 1, 2003; 44(8): 1508 - 1514. [Abstract] [Full Text] [PDF]

				K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H.-P. Zahradnik, H. Wieland, and W. Marz Triglyceride-Rich Lipoproteins Are Associated with Hypertension in Preeclampsia J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1162 - 1166. [Abstract] [Full Text] [PDF]

				H. Jansen, A. J. M. Verhoeven, and E. J. G. Sijbrands Hepatic lipase: a pro- or anti-atherogenic protein? J. Lipid Res., September 1, 2002; 43(9): 1352 - 1362. [Abstract] [Full Text] [PDF]

				K. K. Berneis and R. M. Krauss Metabolic origins and clinical significance of LDL heterogeneity J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379. [Abstract] [Full Text] [PDF]

				J. W. Skeggs and R. E. Morton LDL and HDL enriched in triglyceride promote abnormal cholesterol transport J. Lipid Res., August 1, 2002; 43(8): 1264 - 1274. [Abstract] [Full Text] [PDF]

				H. Campos, D. Perlov, C. Khoo, and F. M. Sacks Distinct patterns of lipoproteins with apoB defined by presence of apoE or apoC-III in hypercholesterolemia and hypertriglyceridemia J. Lipid Res., August 1, 2001; 42(8): 1239 - 1249. [Abstract] [Full Text] [PDF]

				H. L. Dichek, S. M. Johnson, H. Akeefe, G. T. Lo, E. Sage, C. E. Yap, and R. W. Mahley Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice J. Lipid Res., February 1, 2001; 42(2): 201 - 210. [Abstract] [Full Text]

				K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H. Wieland, W. März, and H. P. Zahradnik Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4543 - 4550. [Abstract] [Full Text]

				R. J Havel Genetic underpinnings of LDL size and density: a role for hepatic lipase? Am. J. Clinical Nutrition, June 1, 2000; 71(6): 1390 - 1391. [Full Text] [PDF]

				B. H. Chung and N. Dashti Lipolytic remnants of human VLDL produced in vitro: effect of HDL levels in the lipolysis mixtures on the apoCs to apoE ratio and metabolic properties of VLDL core remnants J. Lipid Res., February 1, 2000; 41(2): 285 - 297. [Abstract] [Full Text]

				N. Bergeron, L. Kotite, M. Verges, P. Blanche, R. L. Hamilton, R. M. Krauss, A. Bensadoun, and R. J. Havel Lamellar lipoproteins uniquely contribute to hyperlipidemia in mice doubly deficient in apolipoprotein E and hepatic lipase PNAS, December 22, 1998; 95(26): 15647 - 15652. [Abstract] [Full Text] [PDF]

				M. J. A. Amar, K. A. Dugi, C. C. Haudenschild, R. D. Shamburek, B. Foger, M. Chase, A. Bensadoun, R. F. Hoyt , Jr., H. B. Brewer , Jr., and S. Santamarina-Fojo Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice J. Lipid Res., December 1, 1998; 39(12): 2436 - 2442. [Abstract] [Full Text]

				S. Qiu, N. Bergeron, L. Kotite, R. M. Krauss, A. Bensadoun, and R. J. Havel Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice J. Lipid Res., August 1, 1998; 39(8): 1661 - 1668. [Abstract] [Full Text]

				H. L. Dichek, W. Brecht, J. Fan, Z.-S. Ji, S. P. A. McCormick, H. Akeefe, L. Conzo, D. A. Sanan, K. H. Weisgraber, S. G. Young, et al. Overexpression of Hepatic Lipase in Transgenic Mice Decreases Apolipoprotein B-containing and High Density Lipoproteins. EVIDENCE THAT HEPATIC LIPASE ACTS AS A LIGAND FOR LIPOPROTEIN UPTAKE J. Biol. Chem., January 23, 1998; 273(4): 1896 - 1903. [Abstract] [Full Text] [PDF]

				C. J. Packard and J. Shepherd Lipoprotein Heterogeneity and Apolipoprotein B Metabolism Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3542 - 3556. [Abstract] [Full Text]

				H. Mezdour, R. Jones, C. Dengremont, G. Castro, and N. Maeda Hepatic Lipase Deficiency Increases Plasma Cholesterol but Reduces Susceptibility to Atherosclerosis in Apolipoprotein E-deficient Mice J. Biol. Chem., May 23, 1997; 272(21): 13570 - 13575. [Abstract] [Full Text] [PDF]

				L. K. Kwong, D. N. Ridinger, M. Bandhauer, J. H. Ward, W. E. Samlowski, P.-H. Iverius, H. Pritchard, and D. E. Wilson Acute Dyslipoproteinemia Induced by Interleukin-2: Lecithin:Cholesteryl Acyltransferase, Lipoprotein Lipase, and Hepatic Lipase Deficiencies J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1572 - 1581. [Abstract] [Full Text] [PDF]

				P. Pajukanta, K. V.K. Porkka, M. Antikainen, M.-R. Taskinen, M. Perola, S. Murtomaki-Repo, S. Ehnholm, I. Nuotio, L. Suurinkeroinen, A.-T. Lahdenkari, et al. No Evidence of Linkage Between Familial Combined Hyperlipidemia and Genes Encoding Lipolytic Enzymes in Finnish Families Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 841 - 850. [Abstract] [Full Text]

				J. Kobayashi, D. Applebaum-Bowden, K. A. Dugi, D. R. Brown, V. S. Kashyap, C. Parrott, C. Duarte, N. Maeda, and S. Santamarina-Fojo Analysis of Protein Structure-Function in Vivo. ADENOVIRUS-MEDIATED TRANSFER OF LIPASE LID MUTANTS IN HEPATIC LIPASE-DEFICIENT MICE J. Biol. Chem., October 18, 1996; 271(42): 26296 - 26301. [Abstract] [Full Text] [PDF]

				H.-O. Mowri, J. R. Patsch, A. M. Gotto Jr, and W. Patsch Apolipoprotein A-II Influences the Substrate Properties of Human HDL2 and HDL3 for Hepatic Lipase Arterioscler. Thromb. Vasc. Biol., June 1, 1996; 16(6): 755 - 762. [Abstract] [Full Text]

				A. T.K. Singh, D. L. Rainwater, S. M. Haffner, J. L. VandeBerg, W. R. Shelledy, P. H. Moore Jr, and T. D. Dyer Effect of Diabetes on Lipoprotein Size Arterioscler. Thromb. Vasc. Biol., November 1, 1995; 15(11): 1805 - 1811. [Abstract] [Full Text]

				K. A. Dugi, H.én L. Dichek, and S. Santamarina-Fojo Human Hepatic and Lipoprotein Lipase: The Loop Covering the Catalytic Site Mediates Lipase Substrate Specificity J. Biol. Chem., October 27, 1995; 270(43): 25396 - 25401. [Abstract] [Full Text] [PDF]

				B. L. Vaisman, H.-G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. HoytJr., S. M. Marcovina, J. J. Albers, et al. Overexpression of Human Lecithin Cholesterol Acyltransferase Leads to Hyperalphalipoproteinemia in Transgenic Mice J. Biol. Chem., May 19, 1995; 270(20): 12269 - 12275. [Abstract] [Full Text] [PDF]